Abstract
Recent studies have established the existence of an innate immune system in the central nervous system (CNS) and implicated a critical role for this system in both normal and pathological processes. Astrocytes and microglia, normal components of the CNS, are the primary cell types that comprise the innate immune system of the CNS. Basic to their role during normal and adverse conditions is the production of neuroimmune factors such as cytokines and chemokines, which are signaling molecules that initiate or coordinate downstream cellular actions. During adverse conditions, cytokines and chemokines function in defensive and repair. However, if expression of these factors becomes dysregulated, abnormal CNS function can result. Both neurons and glial cells of the CNS express receptors for cytokines and chemokines, but the biological consequence of receptor activation has yet to be fully resolved. Our studies show that neuroadaptive changes are produced in primary cultures of rat cerebellar cells chronically treated with the cytokine interleukin-6 (IL-6) and in the cerebellum of transgenic mice that chronically express elevated levels of IL-6 in the CNS. In the cerebellum in culture and in vivo, the neuroadaptive changes included alterations in the level of expression of proteins involved in gene expression, signal transduction, and synaptic transmission. Associated with these changes were alterations in neuronal function. A comparison of results from the cultured cerebellar cells and cerebellum of the transgenic mice indicated that the effects of IL-6 can vary across neuronal types. However, alterations in mechanisms involved in Ca2+ homeostasis were observed in all cell types studied. These results indicate that modifications in cerebellar function are likely to occur in disorders associated with elevated levels of IL-6 in the cerebellum.
Similar content being viewed by others
References
Schobitz B, De Kloet ER, Sutanto W, Holsboer F. Cellular localization of interleukin-6 mRNA and interleukin-6 receptor mRNA in rat brain. Eur J Neurosci. 1993;5:1426–35.
Conroy SM, Nguyen V, Quina LA, Blakely-Gonzales P, Ur C, Netzeband JG, Prieto AL, Gruol DL. Interleukin-6 produces neuronal loss in developing cerebellar granule neuron cultures. J Neuroimmunol. 2004;155:43–54.
Nelson TE, Ur CL, Gruol DL. Chronic interleukin-6 exposure alters electrophysiological properties and calcium signaling in developing cerebellar Purkinje neurons in culture. J Neurophys. 2002;88:475–86.
Sallmann S, Juttler E, Prinz S, Petersen N, Knopf U, Weiser T, Schwaninger M. Induction of interleukin-6 by depolarization of neurons. J Neurosci. 2000;20:8637–42.
Bae JS, Carter JE, Jin HK. Adipose tissue-derived stem cells rescue Purkinje neurons and alleviate inflammatory responses in Niemann-Pick disease type C mice. Cell Tissue Res. 2010;340:357–69.
Wei H, Zou H, Sheikh AM, Malik M, Dobkin C, Brown WT, Li X. IL-6 is increased in the cerebellum of autistic brain and alters neural cell adhesion, migration and synaptic formation. J Neuroinflam. 2011;8:52.
Luzi P, Abraham RM, Rafi MA, Curtis M, Hooper DC, Wenger DA. Effects of treatments on inflammatory and apoptotic markers in the CNS of mice with globoid cell leukodystrophy. Brain Res. 2009;1300:146–58.
Tomita M, Holman BJ, Williams LS, Pang KC, Santoro TJ. Cerebellar dysfunction is associated with overexpression of proinflammatory cytokine genes in lupus. J Neurosci Res. 2001;64:26–33.
Sauder C, de la Torre JC. Cytokine expression in the rat central nervous system following perinatal Borna disease virus infection. J Neuroimmunol. 1999;96:29–45.
Brugg B, Dubreuil YL, Huber G, Wollman EE, Delhaye-B N, Mariani J. Inflammatory processes induce b-amyloid precursor protein changes in mouse brain. PNAS. 1995;92:3032–5.
Ye SM, Johnson RW. Increased interleukin-6 expression by microglia from brain of aged mice. J Neuroimmunol. 1999;93:139–48.
Gruol DL, Puro A, Hao C, Blakely P, Janneke E, Vo K. Neuroadaptive changes in cerebellar neurons induced by chronic exposure to IL-6. J Neuroimmunol. 2011;239:28–36.
Qiu Z, Parsons KL, Gruol DL. Interleukin-6 selectively enhances the intracellular calcium response to NMDA in developing CNS neurons. J Neurosci. 1995;15:6688–99.
Holliday J, Parsons K, Curry J, Lee SY, Gruol DL. Cerebellar granule neurons develop elevated calcium responses when treated with interleukin-6 in culture. Brain Res. 1995;673:141–8.
Nelson TE, Netzeband JG, Gruol DL. Chronic interleukin-6 exposure alters metabotropic glutamate receptor-activated calcium signaling in cerebellar Purkinje neurons. Eur J Neurosci. 2004;20:2387–400.
Acknowledgments
These studies were supported by NIH grants MH083723 and AAO19261
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gruol, D.L. Neuroimmune Regulation of Neurophysiology in the Cerebellum. Cerebellum 12, 307–309 (2013). https://doi.org/10.1007/s12311-012-0445-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12311-012-0445-8